Plasma biomarker profiles and the correlation with cognitive function across the clinical spectrum of Alzheimer’s disease

被引：0
|
作者：
Zhenxu Xiao
Xue Wu
Wanqing Wu
Jingwei Yi
Xiaoniu Liang
Saineng Ding
Li Zheng
Jianfeng Luo
Hongchen Gu
Qianhua Zhao
Hong Xu
Ding Ding
机构：
[1] Fudan University,Institute of Neurology, Huashan Hospital
[2] National Clinical Research Center for Aging and Medicine,School of Biomedical Engineering
[3] Huashan Hospital,Department of Biostatistics, School of Public Health
[4] Fudan University,Key Lab of Public Health Safety of the Ministry of Education
[5] Shanghai Jiao Tong University,undefined
[6] Fudan University,undefined
[7] Fudan University,undefined
来源：
Alzheimer's Research & Therapy | / 13卷
关键词：
Plasma p-tau181; Simoa; Cognitive domain; CDR; Alzheimer’s disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Plasma NfL: a novel Alzheimer's disease biomarker
    不详
    NEUROSCIENTIST, 2019, 25 (05): : 385 - 385
  • [32] Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giacomucci, Giulia
    Mazzeo, Salvatore
    Bagnoli, Silvia
    Ingannato, Assunta
    Leccese, Deborah
    Berti, Valentina
    Padiglioni, Sonia
    Galdo, Giulia
    Ferrari, Camilla
    Sorbi, Sandro
    Bessi, Valentina
    Nacmias, Benedetta
    JOURNAL OF NEUROLOGY, 2022, 269 (08) : 4270 - 4280
  • [33] A Novel Plasma Based Biomarker of Alzheimer's Disease
    Bradley-Whitman, Melissa A.
    Abner, Erin
    Lynn, Bert C.
    Lovell, Mark A.
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 47 (03) : 761 - 771
  • [34] Alzheimer's Disease Plasma Clusterin as a suitable Biomarker?
    Bossenmayer, Susanne
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2011, 79 (09) : 494 - 494
  • [35] Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
    Giulia Giacomucci
    Salvatore Mazzeo
    Silvia Bagnoli
    Assunta Ingannato
    Deborah Leccese
    Valentina Berti
    Sonia Padiglioni
    Giulia Galdo
    Camilla Ferrari
    Sandro Sorbi
    Valentina Bessi
    Benedetta Nacmias
    Journal of Neurology, 2022, 269 : 4270 - 4280
  • [36] Treatment of Alzheimer's disease across the spectrum of severity
    Shah, Shailaja
    Reichman, William E.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (02) : 131 - 142
  • [37] Neuropsychiatric symptoms in cognitive decline and Alzheimer's disease: biomarker discovery using plasma proteomics
    Rabl, Miriam
    Clark, Christopher
    Dayon, Loic
    Popp, Julius
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024,
  • [38] Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum
    Wiesman, Alex, I
    Mundorf, Victoria M.
    Casagrande, Chloe C.
    Wolfson, Sara L.
    Johnson, Craig M.
    May, Pamela E.
    Murman, Daniel L.
    Wilson, Tony W.
    EBIOMEDICINE, 2021, 73
  • [39] Dementia: Biomarker profiles in HIV-associated cognitive disorders and Alzheimer disease
    Yates D.
    Nature Reviews Neurology, 2010, 6 (2) : 59 - 59
  • [40] Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
    Julia Stockmann
    Inge M. W. Verberk
    Nina Timmesfeld
    Robin Denz
    Brian Budde
    Julia Lange-Leifhelm
    Philip Scheltens
    Wiesje M. van der Flier
    Andreas Nabers
    Charlotte E. Teunissen
    Klaus Gerwert
    Alzheimer's Research & Therapy, 12
12345